Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0001437749-26-004946 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-20 | 2026-02-18 | PBYI | NOUGUES MAXIMO F | CFO | A - Grant | $0.00 | +46.7K | 240.0K | +24% | $0 |
| D | 2026-02-20 | 2026-02-18 | PBYI | NOUGUES MAXIMO F | CFO | A - Grant | $0.00 | +66.5K | 66.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | A | A | 46,739 | $0.00 | 240,023 | D | — | — | (F1) Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service with the Company through the applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-18 | A | A | 66,541 | $0.00 | 66,541 | D | $6.68 · — to 2036-02-17 | 66,541 Common Stock | (F2) Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service with the Company through the applicable vesting date. |